| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/07/2009 | WO2008053484A3 Preparation of heavy metal-containing nano-liposomes and their uses in medical therapy |
| 05/07/2009 | WO2008035328A3 Method of organism rejuvenation |
| 05/07/2009 | WO2008018084A3 Peptides derived from plasminogen activator inhibitor for preventing neuronal damage |
| 05/07/2009 | WO2007129999A3 Antiproliferative peptides and antibodies for their detection |
| 05/07/2009 | WO2007094755A3 Compositions and methods for modulating cognitive function |
| 05/07/2009 | WO2007061939A3 Metabolite derivatives of the hdac inhibitor fk228 |
| 05/07/2009 | WO2007059226A3 Photoactivatable antimicrobial agents |
| 05/07/2009 | WO2007056061A3 Concurrent chemotherapy and immunotherapy |
| 05/07/2009 | WO2007055760A3 Protein composition for promoting wound healing and skin regeneration |
| 05/07/2009 | WO2007044804A3 Piperidine derivatives and methods of use |
| 05/07/2009 | WO2007041218A3 Regulation of tool-like receptors on stem cells |
| 05/07/2009 | WO2007028101A3 Osteogenic and anti-adiogenic oxysterols |
| 05/07/2009 | WO2007022455A3 Ubiquitin specific enzymes of family herpesviridae |
| 05/07/2009 | WO2007009019A3 Protein compositions for promoting wound healing and skin regeneration |
| 05/07/2009 | WO2007008684A3 Ligands of melanocortin receptors |
| 05/07/2009 | WO2006135739A3 A novel conotoxin framework with a helix-loop-helix fold |
| 05/07/2009 | WO2006113898A3 Pif tetrapeptides |
| 05/07/2009 | WO2006113210A3 Diagnostic multimarker serological profiling |
| 05/07/2009 | WO2006086330A3 Pharmaceutical compositions |
| 05/07/2009 | WO2006074464A3 Modulating toll-like receptor activity |
| 05/07/2009 | WO2006073417A3 Prophylactic and therapeutic uses of fgf-20 in radiation protection |
| 05/07/2009 | WO2006047788A3 Methods and devices for sustained in-vivo release of an active agent |
| 05/07/2009 | WO2006029398A3 All-trans-retinol : all-trans-13,14-dihydroretinol saturase and methods of its use |
| 05/07/2009 | WO2006026358A3 Sperm specific raft associated proteins |
| 05/07/2009 | WO2006006166A3 Implantable power sources and sensors |
| 05/07/2009 | WO2005112999A3 Cancer treatment with inhibitors of collagen synthesis |
| 05/07/2009 | WO2005089386A3 Methods and compositions for using alveolar macrophage phospholipase a2 |
| 05/07/2009 | US20090119793 Plant Defense Signal Peptides |
| 05/07/2009 | US20090118702 Treatment Medium Delivery Device and Methods for Delivery of Such Treatment Mediums to the Eye Using such a Delivery Device |
| 05/07/2009 | US20090118699 Systems and methods for treating obesity and other gastrointestinal conditions |
| 05/07/2009 | US20090118486 Uspa1 and uspa2 antigens of moraxella catarrhalis |
| 05/07/2009 | US20090118475 Clostridial Neurotoxin Compositions and Modified Clostridial Neurotoxins |
| 05/07/2009 | US20090118473 MN Gene and Protein |
| 05/07/2009 | US20090118469 High-Affinity Antagonists of ELR-CXC Chemokines |
| 05/07/2009 | US20090118219 Flea gaba receptor subunit nucleic acid molecules |
| 05/07/2009 | US20090118210 Epididymal lipocalin gene and uses thereof |
| 05/07/2009 | US20090118209 Use of the slug gene as a genetic marker in functions mediated by SCF (stem cell factor) and applications |
| 05/07/2009 | US20090118205 Antisense Oligonucleotides Directed to Ribonucleotide Reductase R2 and uses Thereof in the Treatment of Cancer |
| 05/07/2009 | US20090118200 Proline bis-amide orexin receptor antagonists |
| 05/07/2009 | US20090118199 Substituted acrylamide derivative and pharmaceutical composition comprising the same |
| 05/07/2009 | US20090118198 Novel peptide derivatives useful as antimicrobial agents for treating wounds |
| 05/07/2009 | US20090118197 Immune-Modulating Peptide |
| 05/07/2009 | US20090118196 LKKTET And/Or LKKTNT Peptide Compositions Which Are Lyophilized Or In A Form Capable of Being Lyophilized |
| 05/07/2009 | US20090118195 Molecules Which Promote Hematopoiesis |
| 05/07/2009 | US20090118194 Measurement of melanocortin peptides and uses thereof |
| 05/07/2009 | US20090118193 Pegylated mutated clostridium botulinum toxin |
| 05/07/2009 | US20090118192 sequentially administering parathyroid hormone and bone resorption inhibitor; bone disorders; osteoporosis |
| 05/07/2009 | US20090118191 Anti-Antiogenic Fragments of Pigment Epithelium-Derived Factor (PEDF) |
| 05/07/2009 | US20090118190 Muteins of fibroblast growth factor 21 |
| 05/07/2009 | US20090118189 Novel angiogenic composition-based methods |
| 05/07/2009 | US20090118188 Activin-actriia antagonists and uses for decreasing or inhibiting FSH secretion |
| 05/07/2009 | US20090118187 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto |
| 05/07/2009 | US20090118186 administering to a cancer patient a soluble tumor necrosis factor related apoptosis inducing ligand (TRAIL) polypeptide, selected from the extracellular domain of human TRAIL or fragment thereof, in the form of an oligomer; treatment of leukemia, melanoma or lymphoma |
| 05/07/2009 | US20090118185 Recombinant factor viii having reduced inactivation by activated protein c |
| 05/07/2009 | US20090118184 Recombinant factor viii having increased stability |
| 05/07/2009 | US20090118183 Erythropoietin receptor peptide formulations and uses |
| 05/07/2009 | US20090118182 Fibroblast Growth Factor-Like Polypeptides |
| 05/07/2009 | US20090118181 Compositions and methods for producing bioactive fusion proteins |
| 05/07/2009 | US20090118180 Use of fusion proteins for the prevention or the treatment of pathologies resulting from ischemia |
| 05/07/2009 | US20090118179 topically administering a fibroblast growth factor; treating a tooth with a dental parenchyma loss due to dental caries, tooth attrition or injury; promoting cell proliferation and differentiation; dentistry |
| 05/07/2009 | US20090118178 Y4 selective receptor agonists for therapeutic interventions |
| 05/07/2009 | US20090118177 Use of nerve growth factor in eye-drops for therapy of pathologies of the central nervous system, such as alzheimer's and parkinson's disease |
| 05/07/2009 | US20090118176 Stem Cell Factor-Like Protein Scfa1 and Uses Thereof |
| 05/07/2009 | US20090118175 Compositions and Methods for Detection, Prognosis and Treatment of Breast Cancer |
| 05/07/2009 | US20090118174 Novel peptides and methods for the treatment of inflammatory disorders |
| 05/07/2009 | US20090118173 Treatment and prevention of inflammatory bowel diseases |
| 05/07/2009 | US20090118172 Shortened glucagon-like peptide 1(sglp-1) preparation method and application |
| 05/07/2009 | US20090118171 Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune |
| 05/07/2009 | US20090118170 Buccal, polar and non-polar spray or capsule |
| 05/07/2009 | US20090118169 Novel compounds and pharmaceutical use thereof |
| 05/07/2009 | US20090118168 Topical adminstration of acyclovir |
| 05/07/2009 | US20090118167 Selective Vpac2 Receptor Peptide Agonists |
| 05/07/2009 | US20090118166 Conditioned Decellularized Native Tissues for Tissue Restoration |
| 05/07/2009 | US20090118165 Method of treating chemotherapy-induced thrombocytopenia |
| 05/07/2009 | US20090118164 Methods and compounds for the targeted delivery of agents to bone for interaction therewith |
| 05/07/2009 | US20090118163 Factor H for the Treatment of Chronic Nephropathies and Production thereof |
| 05/07/2009 | US20090118162 Inhibitors of serine protease activity and their use in methods and compositions for treatment of graft rejection and promotion of graft survival |
| 05/07/2009 | US20090118161 Treatment of medical condition with a2 domain of von willebrand factor |
| 05/07/2009 | US20090118160 Heterocyclic compounds and methods of use |
| 05/07/2009 | US20090118159 glucokinase activator 3-{[5-(azetidin-1-ylcarbonyl)pyrazin-2-yl]oxy}-5-{[(1S)-1-methyl-2-(methyloxy)ethyl]oxy}-N-(5-methylpyrazin-2-yl)benzamide or a salt thereof; chemical synthesis to obtain antidiabetic agent |
| 05/07/2009 | US20090118158 peptide YY, Neuropeptide Y, or Pancreatic polypeptide with solubilizing agent (cyclodextran), chelating agent (ethylenediamine tetraacetic acid), pH control agent (arginine, sodium hydroxide, glycine, hydrochloric acid) and preservatives ( methylparaben or propylparaben); eating disorder |
| 05/07/2009 | US20090117662 Mutants of IGF Binding Proteins and Methods of Production of Antagonists Thereof |
| 05/07/2009 | US20090117652 in vitro use of granulocyte chemotactic protein-2 (CXCL6) to promote cartilage (and underlying bone) formation e.g. in the repair of cartilage or osteochondral defects; osteoarthritis |
| 05/07/2009 | US20090117586 Fungal cell wall synthesis gene |
| 05/07/2009 | US20090117565 Compositions and methods for diagnosis and treating mood disorders |
| 05/07/2009 | US20090117216 treating obesity, diabetes, inflammation, or cancer in a mammal with a biosynthesized protein from culturing microorganisms of algae or bacteria; viral infections, oxidative stress, cardiovascular diseases, immune system disorders, metabolic disorders, HIV, or gastric reflux disease |
| 05/07/2009 | US20090117195 Hydrophilic Particles Based on Cationic Chitosan Derivatives |
| 05/07/2009 | US20090117193 Compositions Comprising an Active Agent |
| 05/07/2009 | US20090117189 Method for the Production of Polymerized Nanoparticles and Microparticles by Ternary Agent Concentration and Temperature Alteration Induced Immiscibility |
| 05/07/2009 | US20090117187 Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure |
| 05/07/2009 | US20090117185 2-(Aminomethyl)-5-Chlorobenzylamide Derivatives and their use as Inhibitors of the Clotting Factor Xa |
| 05/07/2009 | US20090117180 Stable digestive enzyme compositions |
| 05/07/2009 | US20090117178 with immunogenic or therapeutic properties against ischemic cardiovascular diseases; atherosclerosis |
| 05/07/2009 | US20090117166 Sequential coupling of biomolecule layers to polymers |
| 05/07/2009 | US20090117158 Transdermal sustained release drug delivery |
| 05/07/2009 | US20090117145 Composition and Method For Enhancing Immune Response |
| 05/07/2009 | US20090117143 Recombinant adenylate cyclase toxin of bordetella induces T cell responses against tumoral antigens |
| 05/07/2009 | US20090117140 Human papilloma virus dominant CD4 T cell epitopes and uses thereof |
| 05/07/2009 | US20090117139 Lutzomyia longipalpis polypeptides and methods of use |
| 05/07/2009 | US20090117138 Vaccine for a therapeutic or a prophylactic treatment of myasthenia gravis |